17-42201524-GCACACACACACACACACACACACA-GCACACACACACACACACACACACACACACACA

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_012448.4(STAT5B):​c.*206_*213dupTGTGTGTG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000454 in 617,316 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 21)
Exomes 𝑓: 0.000055 ( 0 hom. )

Consequence

STAT5B
NM_012448.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.111

Publications

0 publications found
Variant links:
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
  • growth hormone insensitivity syndrome with immune dysregulation
    Inheritance: SD Classification: DEFINITIVE Submitted by: Illumina
  • growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • growth hormone insensitivity with immune dysregulation 1, autosomal recessive
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • growth hormone insensitivity syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012448.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
NM_012448.4
MANE Select
c.*206_*213dupTGTGTGTG
3_prime_UTR
Exon 19 of 19NP_036580.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
ENST00000293328.8
TSL:1 MANE Select
c.*206_*213dupTGTGTGTG
3_prime_UTR
Exon 19 of 19ENSP00000293328.3P51692
STAT5B
ENST00000951702.1
c.*206_*213dupTGTGTGTG
3_prime_UTR
Exon 20 of 20ENSP00000621761.1
STAT5B
ENST00000415845.2
TSL:4
c.*206_*213dupTGTGTGTG
3_prime_UTR
Exon 19 of 19ENSP00000398379.2P51692

Frequencies

GnomAD3 genomes
AF:
0.0000137
AC:
2
AN:
145742
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000694
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000152
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000551
AC:
26
AN:
471574
Hom.:
0
Cov.:
0
AF XY:
0.0000603
AC XY:
15
AN XY:
248626
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
13910
American (AMR)
AF:
0.000143
AC:
4
AN:
28030
Ashkenazi Jewish (ASJ)
AF:
0.000129
AC:
2
AN:
15526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31060
South Asian (SAS)
AF:
0.000121
AC:
6
AN:
49586
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30836
Middle Eastern (MID)
AF:
0.000477
AC:
1
AN:
2098
European-Non Finnish (NFE)
AF:
0.0000366
AC:
10
AN:
273556
Other (OTH)
AF:
0.000111
AC:
3
AN:
26972
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000137
AC:
2
AN:
145742
Hom.:
0
Cov.:
21
AF XY:
0.0000141
AC XY:
1
AN XY:
70740
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40140
American (AMR)
AF:
0.0000694
AC:
1
AN:
14404
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3338
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4912
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4526
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
304
European-Non Finnish (NFE)
AF:
0.0000152
AC:
1
AN:
65694
Other (OTH)
AF:
0.00
AC:
0
AN:
1948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
15

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.11

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57573850; hg19: chr17-40353542; API